IMIXBoardglobenewswire

Nancy T. Chang, Proven Biotechnology Leader, Joins Immix Biopharma Board of Directors

Sentiment:Positive (70)

Summary

(IMIX) – Dr. Chang led XOLAIR® from invention through FDA approval and commercialization, exceeding $5 billion in sales so far –

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on September 11, 2025 by globenewswire

    Nancy T. Chang, Proven Biotechnology Leader, Joins Immix Biopharma Board of Directors | IMIX Stock News | Candlesense